Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Oncotarget
|
October 6, 2017
Decreased WWOX expression promotes angiogenesis in osteosarcoma
Jia Wen, Zongchao Xu, Jiazhen Li, et al.
Thyroid Research
|
February 9, 2025
BRAF<sup>V600E</sup> mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials
Di Sun, Xin Zhang, Xiaona Jin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 6, 2024
Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer
Di Sun, Xin Zhang, Yuqing Sun, et al.
Cancer Medicine
|
July 18, 2020
Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling
Wenlin Xie, Yingqiang Zhang, Bingyang Wang, et al.
Therapeutic Advances in Medical Oncology
|
August 6, 2020
Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma
Yingqiang Zhang, Guihua Huang, Hongfei Miao, et al.
The Oncologist
|
October 9, 2015
Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
Yingqiang Zhang, Wenzhe Fan, Yu Wang, et al.
Frontiers in Neurology
|
September 29, 2025
Predictive factors of successful endovascular recanalization for symptomatic atherosclerotic non-acute middle cerebral artery occlusion
Lin Ma, Hao Zhang, Shuo Yan, et al.
Leukemia & Lymphoma
|
December 5, 2019
Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas
Long Qian, Miaoming Yan, Wei Zhang, et al.
European Radiology
|
July 31, 2020
The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
Yingqiang Zhang, Hongfei Miao, Wenlin Xie, et al.
The Oncologist
|
August 4, 2016
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience
Yingqiang Zhang, Guihua Huang, Yu Wang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Oncotarget
|
October 6, 2017
Decreased WWOX expression promotes angiogenesis in osteosarcoma
Jia Wen, Zongchao Xu, Jiazhen Li, et al.
Thyroid Research
|
February 9, 2025
BRAF<sup>V600E</sup> mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials
Di Sun, Xin Zhang, Xiaona Jin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 6, 2024
Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer
Di Sun, Xin Zhang, Yuqing Sun, et al.
Cancer Medicine
|
July 18, 2020
Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling
Wenlin Xie, Yingqiang Zhang, Bingyang Wang, et al.
Therapeutic Advances in Medical Oncology
|
August 6, 2020
Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma
Yingqiang Zhang, Guihua Huang, Hongfei Miao, et al.
The Oncologist
|
October 9, 2015
Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
Yingqiang Zhang, Wenzhe Fan, Yu Wang, et al.
Frontiers in Neurology
|
September 29, 2025
Predictive factors of successful endovascular recanalization for symptomatic atherosclerotic non-acute middle cerebral artery occlusion
Lin Ma, Hao Zhang, Shuo Yan, et al.
Leukemia & Lymphoma
|
December 5, 2019
Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas
Long Qian, Miaoming Yan, Wei Zhang, et al.
European Radiology
|
July 31, 2020
The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
Yingqiang Zhang, Hongfei Miao, Wenlin Xie, et al.
The Oncologist
|
August 4, 2016
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience
Yingqiang Zhang, Guihua Huang, Yu Wang, et al.
Page
of 6